Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Vor Biopharma Inc shares valued at $12,918 were sold by Attar Eyal C. on Dec 27 ’24. At $1.25 per share, Attar Eyal C. sold 10,334 shares. The insider’s holdings dropped to 81,439 shares worth approximately $0.12 million following the completion of this transaction.
Also, EYAL ATTAR purchased 10,334 shares, netting a total of over 8,660 in proceeds.
Before that, Attar Eyal C. had sold 14,645 shares from its account. In a trade valued at $20,357, the CHIEF MEDICAL OFFICER traded Vor Biopharma Inc shares for $1.39 each. Upon closing the transaction, the insider’s holdings decreased to 14,645 shares, worth approximately $0.14 million.
As published in their initiating research note from Wedbush on July 26, 2022, Vor Biopharma Inc [VOR] has been an Outperform and the price target has been revised to $18. Analysts at Goldman started covering the stock with ‘”a Neutral”‘ outlook in a report released in late April. As of December 17, 2021, H.C. Wainwright has initiated its “Buy” rating for VOR. Earlier on December 03, 2021, Robert W. Baird initiated its rating. Their recommendation was “an Outperform” for VOR stock.
Analyzing VOR Stock Performance
During the last five days, there has been a surge of approximately 5.80%. Over the course of the year, Vor Biopharma Inc shares have jumped approximately 31.53%. Shares of the company reached a 52-week high of $1.8000 on 01/06/25 and a 52-week low of $1.0800 on 01/02/25. A 50-day SMA is recorded $1.1510, while a 200-day SMA reached $1.0905. Nevertheless, trading volume fell to 0.56 million shares from 0.26 million shares the previous day.
Support And Resistance Levels for Vor Biopharma Inc (VOR)
According to the 24-hour chart, there is a support level at 1.3739, which, if violated, would cause prices to drop to 1.2877. In the upper region, resistance lies at 1.5131. The next price resistance is at 1.5661. RSI (Relative Strength Index) is 57.99 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0042, which suggests the price will decrease in the coming days. Percent R is at 35.14%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
